Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Donate
Dr. Andrew M. Tonkin comments on the results of the UMPIRE trial, delcaring it to be "an important trial."
